Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Basal Cell Carcinoma”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Early research (Phase 1)Study completedNCT01106508
What this trial is testing

A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsRecurrent or Refractory MedulloblastomaLocally Advanced or Metastatic Basal Cell Carcinoma
Novartis Pharmaceuticals 57
Not applicableStudy completedNCT07068568
What this trial is testing

Dose-Modulated Sonidegib Therapy for Periocular Basal Cell Carcinoma

Who this might be right for
Basal Cell CancerEyelid TumorBasal Cell Carcinoma (BCC)+1 more
Federico II University 12
Not applicableApproved For MarketingNCT01160250
What this trial is testing

Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Genentech, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07227350
What this trial is testing

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

Who this might be right for
Locally Advanced Basal Cell Carcinoma
Philogen S.p.A. 180
Early research (Phase 1)Study completedNCT03458117
What this trial is testing

T-VEC in Non-melanoma Skin Cancer

Who this might be right for
Non-melanoma Skin CancerBasal Cell CarcinomaSquamous Cell Carcinoma+2 more
University of Zurich 26
Early research (Phase 1)Study completedNCT00019110
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

Who this might be right for
Anal CancerCervical CancerEsophageal Cancer+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06344052
What this trial is testing

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Stamford Pharmaceuticals, Inc. 80
Post-approval studies (Phase 4)Study completedNCT06880848
What this trial is testing

Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China

Who this might be right for
Carcinoma, Basal Cell (BCC)
Jemincare 160
Testing effectiveness (Phase 2)Looking for participantsNCT03521830
What this trial is testing

Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 57
Testing effectiveness (Phase 2)Study completedNCT01367665
What this trial is testing

STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Hoffmann-La Roche 1,232
Early research (Phase 1)Study completedNCT00968981
What this trial is testing

Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

Who this might be right for
Solid Cancers
Genentech, Inc. 67
Large-scale testing (Phase 3)Active Not RecruitingNCT05078047
What this trial is testing

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Who this might be right for
Lung Cancer MetastaticRenal Cell CarcinomaHead and Neck Cancer+12 more
UNICANCER 646
Not applicableStudy completedNCT02781389
What this trial is testing

Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions

Who this might be right for
Basal Cell Carcinoma
University Hospital, Essen 53
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Not applicableStudy completedNCT02674009
What this trial is testing

Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC)

Who this might be right for
Carcinoma, Basal Cell
Hoffmann-La Roche 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT04806646
What this trial is testing

Tailored Sonidegib Schedule After Complete Response in BCC

Who this might be right for
Locally Advanced Basal Cell Carcinoma
Gruppo Oncologico del Nord-Ovest 21
Not applicableStudy completedNCT04066504
What this trial is testing

Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Sun Pharmaceutical Industries Limited 323
Testing effectiveness (Phase 2)Study completedNCT02354261
What this trial is testing

Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)

Who this might be right for
Basal Cell Carcinoma in Basal Cell Nevus Syndrome
HedgePath Pharmaceuticals, Inc. 38
Testing effectiveness (Phase 2)Study completedNCT01835626
What this trial is testing

Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma

Who this might be right for
Locally Advanced Basal Cell CarcinomaSkin CancerCutaneous Malignancy
Sue Yom 24
Testing effectiveness (Phase 2)Looking for participantsNCT05561634
What this trial is testing

Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma

Who this might be right for
Basal Cell CarcinomaRadiotherapy; Complications
University Hospital, Lille 82
Next Page